The Use of Fenestrated Dehydrated Complete Human Placental Membrane Allografts in a Dermatologic Excision Defect
View ReportA Selective Barrier Designed to Provide Protection for Acute and Chronic Wounds
Relese is a fenestrated dehydrated complete human placental membrane (dCHPM) allograft. Fenestration of the allograft creates a selective barrier that protects the wound from the surrounding environment while allowing wound exudate to drain. Through the patented Clearify® technology, all three layers of the native placental membrane (amnion, intermediate layer, and chorion) and key structural proteins and components are retained.1
Case Reports
Common Clinical Applications
Acute and chronic wounds such as:
- Dermatologic Wounds
- Diabetic Ulcers
- Pressure Ulcers
- Surgical Wounds
- Traumatic Wounds
- Venous Ulcers
*Relese is intended to be used as a selective barrier.
Commonly used in specialties such as:
- Dermatology
- General Surgery
- Orthopedic Surgery
- Plastic Surgery
- Podiatry
- Vascular Surgery
Common Anatomical Applications
Sizes & SKUs
Size | 2 x 3 cm | 4 x 4 cm | 6 x 8 cm |
---|---|---|---|
SKU | RL-2030 | RL-4040 | RL-6080 |
Sheet Format | Shelf-stable for up to five (5) years
Related Resources
- Data on file.
- Data is compared to the leading dual-layer allograft and reported as an average.
- Manna B, Cooper JS. Radiation Therapy-Induced Skin Ulcer. [Updated 2023 Apr 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-.
- Sano, M., Yamamoto, K., Seo, A., Akai, A., Akagi, D., Takayama, T., & Hoshina, K. (2019). Wound healing after revascularization for critical limb ischemia. International angiology : a journal of the International Union of Angiology, 38(3), 225–229. https://doi.org/10.23736/S0392-9590.19.04096-3
- Hingorani, A., LaMuraglia, G. M., Henke, P., Meissner, M. H., Loretz, L., Zinszer, K. M., Driver, V. R., Frykberg, R., Carman, T. L., Marston, W., Mills, J. L., Sr, & Murad, M. H. (2016). The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. Journal of vascular surgery, 63(2 Suppl), 3S–21S. https://doi.org/10.1016/j.jvs.2015.10.003
Patents: www.stimlabs.com/patents
© 2016-2024 Stimlabs® LLC; STIMLABS, REVITA, COGENEX, ENVERSE, VIALIZE, RELESE, CLEARIFY, and CORPLEX P are registered trademarks of Stimlabs LLC.